Uncategorised - European Medical Journal

Phase IIb Study Design of Inhaled Pirfenidone for Progressive Pulmonary Fibrosis Treatment

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of pulmonary…

The Future of Lung Transplantation in Cystic Fibrosis

AN INSIGHTFUL session on the future of lung transplantation presented at this year’s European Respiratory Society (ERS) Congress explored…

ERS 2024 Abstract Highlights

The following abstract highlights spotlight selected abstracts presented at the European Respiratory Society (ERS) Congress 2024. They…

Patient–Planet Priority in Respiratory Care

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address health…

Inflammatory Processes in COPD

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes resulting in airway…

Understanding Bronchiectasis Pathogenesis and Exacerbation

The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by symptoms such as…

Precision Strikes: Personalising Stage IIIA Lung Cancer Treatment with Targeted and Immune Therapies

The treatment landscape for potentially surgically resectable Stage IIIA non-small cell lung cancer (NSCLC), particularly for…

Advancing Respiratory Care: The Role of Simulation in Clinical Education

The demand for highly skilled respiratory clinicians grows as respiratory care becomes increasingly complex with rapid advancement…

Pleural Metastasis of Papillary Thyroid Cancer: Clinical Implications

Papillary thyroid cancer (PTC) is the most common form of thyroid cancer, accounting for 80–85% of thyroid cancer cases…

Can Diet Quality Slow Prostate Cancer?

Diet quality could play a role in the progression of prostate cancer for men undergoing active surveillance.